IRINOTECAN INTAS irinotecan hydrochloride trihydrate 500 mg/25 mL concentrated injection vial

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Bahan aktif:

irinotecan hydrochloride trihydrate, Quantity: 500 mg

Boleh didapati daripada:

Accord Healthcare Pty Ltd

Borang farmaseutikal:

Injection, concentrated

Komposisi:

Excipient Ingredients: sorbitol; hydrochloric acid; sodium hydroxide; water for injections; lactic acid

Laluan pentadbiran:

Intravenous Infusion

Unit dalam pakej:

1

Jenis preskripsi:

(S4) Prescription Only Medicine

Tanda-tanda terapeutik:

Irinotecan hydrochloride is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. Irinotecan hydrochloride is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

Ringkasan produk:

Visual Identification: A pale yellow clear solution; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Status kebenaran:

Registered

Tarikh kebenaran:

2020-03-05